2096: Simcere Pharmaceutical Group Limited - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Simcere Pharmaceutical Group Limited

HKG:2096

SummaryFactSheetFinancial
Price
HK$12.10
Loss Chance
47.5%
5.59JITTA SCORE
298.00%Over Jitta Line
Jitta Ranking
Pharmaceuticals
6 / 48
Health Care
26 / 225
Hong Kong
?
261 / 2,478
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Sino Biopharmaceutical Limited
HKG:1177
6.49
HK$5.48
316.37%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
HKG:1276
7.55
HK$65.70
158.05%
JBM (Healthcare) Limited
HKG:2161
7.32
HK$2.48
65.01%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKG:2196
6.18
HK$19.96
42.68%
Dawnrays Pharmaceutical (Holdings) Limited
HKG:2348
4.42
HK$1.13
26.09%
Jitta Factors
Growth Opportunity (66)
Recent Business Performance (85)
Financial Strength (69)
Return to Shareholders (38)
Competitive Advantage (57)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Revenue and EarningEarning decline from 2019-2024
Operating MarginInconsistent
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.59
298.00%
4.29
286.37%
3.71
298.72%
Pharmaceuticals
6.49
316.37%
7.55
158.05%
7.32
65.01%
COMPANY DESCRIPTION
Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.
www.simcere.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.